Potential advantage of therapeutic plasma exchange over intravenous immunoglobulin in children with axonal variant of Guillain-Barré syndrome: A report of six paediatric cases
- 21 November 2024
- journal article
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 32 (1) , 112-117
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special IssueJournal of Clinical Apheresis, 2023
- Successful treatment with therapeutic plasmapheresis of a pediatric patient with Guillain‐Barré syndrome associated with neurobrucellosisJournal of Clinical Apheresis, 2022
- A CASE OF IVIG REFRACTORY GUILLAIN-BARRÉ SYNDROME IN THE SETTING OF SUBCLINICAL COVID-19 INFECTIONChest, 2021
- Axonal variants of Guillain–Barré syndrome: an updateJournal of Neurology, 2020
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special IssueJournal of Clinical Apheresis, 2019
- Cost‐minimization analysis in the Indian subcontinent for treating Guillain Barre Syndrome patients with therapeutic plasma exchange as compared to intravenous immunoglobulinJournal of Clinical Apheresis, 2018
- Guillain-Barré Syndrome and VariantsNeurologic Clinics, 2013
- Antiganglioside antibodies determine the clinical severity and predict response to therapy in Egyptian children with Guillain–Barré SyndromePediatria Polska, 2013
- Intravenous immunoglobulin therapy for Guillain-Barr syndrome with IgG anti-GM1 antibodyMuscle & Nerve, 2001
- Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in ChinaAnnals of Neurology, 1993